Specificity of staphylococcal superantigen-like protein 10 toward the human IgG1 Fc domain

Journal of Immunology

Volumn 184, Issue 11, 2010, Pages 6283-6292

  Patel, Deepa ^a   Wines, Bruce D ^b   Langley, Ries J ^a   Fraser, John D ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b BURNET INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1Q; FIBRINOGEN; FIBRONECTIN; IMMUNOGLOBULIN G1; OLIGONUCLEOTIDE; STAPHYLOCOCCAL SUPERANTIGEN LIKE PROTEIN 10; SUPERANTIGEN; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; VIRULENCE FACTOR;

ANTIGEN BINDING; ANTIGEN SPECIFICITY; ARTICLE; BINDING SITE; CONTROLLED STUDY; HUMAN; MONOCYTE; MUTAGENESIS; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DOMAIN; STAPHYLOCOCCUS AUREUS; AMINO ACID SEQUENCE; ANIMAL; ANTIBODY SPECIFICITY; CATTLE; CELL SEPARATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETICS; GUINEA PIG; IMMUNOLOGY; IMMUNOPRECIPITATION; METABOLISM; MOLECULAR GENETICS; MOUSE; PATHOGENICITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; RABBIT; SEQUENCE HOMOLOGY; SPECIES DIFFERENCE; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODY SPECIFICITY; BACTERIAL PROTEINS; BLOTTING, WESTERN; CATTLE; CELL SEPARATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GUINEA PIGS; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; IMMUNOPRECIPITATION; MICE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RABBITS; SEQUENCE HOMOLOGY, AMINO ACID; SPECIES SPECIFICITY; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; VIRULENCE FACTORS;

EID: 77953386609     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903311     Document Type: Article

References (52)

1. Morgan, B. P., and M. J. Walport. 1991. Complement deficiency and disease. Immunol. Today 12: 301-306.
2. Burg, N. D., and M. H. Pillinger. 2001. The neutrophil: function and regulation in innate and humoral immunity. Clin. Immunol. 99: 7-17.
3. Middleton, J., A. M. Patterson, L. Gardner, C. Schmutz, and B. A. Ashton. 2002. Leukocyte extravasation: chemokine transport and presentation by the endothelium. Blood 100: 3853-3860.
4. Gessner, J. E., H. Heiken, A. Tamm, and R. E. Schmidt. 1998. The IgG Fc receptor family. Ann. Hematol. 76: 231-248.
5. Klickstein, L. B., S. F. Barbashov, T. Liu, R. M. Jack, and A. Nicholson-Weller. 1997. Complement receptor type 1 (CR1, CD35) is a receptor for C1q. Immunity 7: 345-355.
6. Kuroda, M., T. Ohta, I. Uchiyama, T. Baba, H. Yuzawa, I. Kobayashi, L. Cui, A. Oguchi, K. Aoki, Y. Nagai, et al. 2001. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 357: 1225-1240.
7. Jongerius, I., J. Köhl, M. K. Pandey, M. Ruyken, K. P. van Kessel, J. A. van Strijp, and S. H. Rooijakkers. 2007. Staphylococcal complement evasion by various convertase-blocking molecules. J. Exp. Med. 204: 2461-2471.
8. Smyth, D. S., W. J. Meaney, P. J. Hartigan, and C. J. Smyth. 2007. Occurrence of ssl genes in isolates of Staphylococcus aureus from animal infection. J. Med. Microbiol. 56: 418-425.
9. Fitzgerald, J. R., S. D. Reid, E. Ruotsalainen, T. J. Tripp, M. Liu, R. Cole, P. Kuusela, P. M. Schlievert, A. Järvinen, and J. M. Musser. 2003. Genome diversification in Staphylococcus aureus: molecular evolution of a highly variable chromosomal region encoding the staphylococcal exotoxin-like family of proteins. Infect. Immun. 71: 2827-2838.
10. Al-Shangiti, A. M., S. P. Nair, and B. M. Chain. 2005. The interaction between staphylococcal superantigen-like proteins and human dendritic cells. Clin. Exp. Immunol. 140: 461-469.
11. Torres, V. J., D. L. Stauff, G. Pishchany, J. S. Bezbradica, L. E. Gordy, J. Iturregui, K. L. Anderson, P. M. Dunman, S. Joyce, and E. P. Skaar. 2007. A Staphylococcus aureus regulatory system that responds to host heme and modulates virulence. Cell Host Microbe 1: 109-119.
12. Corbin, B. D., E. H. Seeley, A. Raab, J. Feldmann, M. R. Miller, V. J. Torres, K. L. Anderson, B. M. Dattilo, P. M. Dunman, R. Gerads, et al. 2008. Metal chelation and inhibition of bacterial growth in tissue abscesses. Science 319: 962-965.
13. Stauff, D. L., D. Bagaley, V. J. Torres, R. Joyce, K. L. Anderson, L. Kuechenmeister, P. M. Dunman, and E. P. Skaar. 2008. Staphylococcus aureus HrtA is an ATPase required for protection against heme toxicity and prevention of a transcriptional heme stress response. J. Bacteriol. 190: 3588-3596.
14. Arcus, V. 2002. OB-fold domains: a snapshot of the evolution of sequence, structure and function. Curr. Opin. Struct. Biol. 12: 794-801.
15. Arcus, V. L., R. Langley, T. Proft, J. D. Fraser, and E. N. Baker. 2002. The three-dimensional structure of a superantigen-like protein, SET3, from a pathogenicity island of the Staphylococcus aureus genome. J. Biol. Chem. 277: 32274-32281.
16. Fraser, J. D., and T. Proft. 2008. The bacterial superantigen and superantigen-like proteins. Immunol. Rev. 225: 226-243.
17. Al-Shangiti, A. M., C. E. Naylor, S. P. Nair, D. C. Briggs, B. Henderson, and B. M. Chain. 2004. Structural relationships and cellular tropism of staphylococcal superantigen-like proteins. Infect. Immun. 72: 4261-4270.
18. Langley, R., B. Wines, N. Willoughby, I. Basu, T. Proft, and J. D. Fraser. 2005. The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-FcαRI binding and serum killing of bacteria. J. Immunol. 174: 2926-2933.
19. Wines, B. D., N. Willoughby, J. D. Fraser, and P. M. Hogarth. 2006. A competitive mechanism for staphylococcal toxin SSL7 inhibiting the leukocyte IgA receptor, Fc αRI, is revealed by SSL7 binding at the C α2/C α3 interface of IgA. J. Biol. Chem. 281: 1389-1393.
20. Chung, M. C., B. D. Wines, H. Baker, R. J. Langley, E. N. Baker, and J. D. Fraser. 2007. The crystal structure of staphylococcal superantigen-like protein 11 in complex with sialyl Lewis X reveals the mechanism for cell binding and immune inhibition. Mol. Microbiol. 66: 1342-1355.
21. Baker, H. M., I. Basu, and E. N. Baker. 2007. Crystal structure of the staphylococcal toxin SSL5 in complex with sialyl Lewis X reveal a conserved binding site that shares common features with viral and bacterial sialic acid binding proteins. J. Mol. Biol. 374: 1298-1308.
22. Ramsland, P. A., N. Willoughby, H. M. Trist, W. Farrugia, P. M. Hogarth, J. D. Fraser, and B. D. Wines. 2007. Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1. Proc. Natl. Acad. Sci. USA 104: 15051-15056.
23. Laursen, N. S., N. Gordon, S. Hermans, N. Lorenz, N. Jackson, B. Wines, E. Spillner, J. B. Christensen, M. Jensen, F. Fredslund, et al. 2010. Structural basis for inhibition of complement C5 by the SSL7 protein from Staphylococcus aureus. Proc. Natl. Acad. Sci. USA 107: 3681-3686.
24. Itoh, S., E. Hamada, G. Kamoshida, R. Yokoyama, T. Takii, K. Onozaki, and T. Tsuji. 2010. Staphylococcal superantigen-like protein 10 (SSL10) binds to human immunoglobulin G (IgG) and inhibits complement activation via the classical pathway. Mol. Immunol. 47: 932-938.
25. Shevchenko, A., M. Wilm, O. Vorm, and M. Mann. 1996. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68: 850-858.
26. Evans, M. J., S. L. Hartman, D. W. Wolff, S. A. Rollins, and S. P. Squinto. 1995. Rapid expression of anti-human C5 chimeric Fab utilizing a vector that replicates in COS and 293 cells. J. Immunol. Methods 184: 123-138.
27. Holden, M. T. G., E. J. Feil, J. A. Lindsay, S. J. Peacock, N. P. J. Day, M. C. Enright, T. J. Foster, C. E. Moore, L. Hurst, R. Atkin, et al. 2004. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc. Natl. Acad. Sci. USA 101: 9786-9791.
28. Bendtsen, J. D., H. Nielsen, G. von Heijne, and S. Brunak. 2004. Improved prediction of signal peptides: SignalP 3.0. J. Mol. Biol. 340: 783-795.
29. Porter, R. R. 1959. The hydrolysis of rabbit γ-globulin and antibodies with crystalline papain. Biochem. J. 73: 119-126.
30. Hezareh, M., A. J. Hessell, R. C. Jensen, J. G. van de Winkel, and P. W. Parren. 2001. Effector function activities of a panel of mutants of a broadly neutralizing antibody against human immunodeficiency virus type 1. J. Virol. 75: 12161-12168.
31. Hessell, A. J., L. Hangartner, M. Hunter, C. E. Havenith, F. J. Beurskens, J. M. Bakker, C. M. Lanigan, G. Landucci, D. N. Forthal, P. W. Parren, et al. 2007. Fc receptor but not complement binding is important in antibody protection against HIV. Nature 449: 101-104.
32. Sondermann, P., R. Huber, V. Oosthuizen, and U. Jacob. 2000. The 3.2-A crystal structure of the human IgG1 Fc fragment-FcγRIII complex. Nature 406: 267-273. (Pubitemid 30604397)
33. Kang, H. J., F. Coulibaly, F. Clow, T. Proft, and E. N. Baker. 2007. Stabilizing isopeptide bonds revealed in Gram-positive bacterial pilus structure. Science 318: 1625-1628.
34. Idusogie, E. E., L. G. Presta, H. Gazzano-Santoro, K. Totpal, P. Y. Wong, M. Ultsch, Y. G. Meng, and M. G. Mulkerrin. 2000. Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc. J. Immunol. 164: 4178-4184.
35. Burmeister,W. P., A. H. Huber, and P. J. Bjorkman. 1994. Crystal structure of the complex of rat neonatal Fc receptor with Fc. Nature 372: 379-383.
36. Nimmerjahn, F., and J. V. Ravetch. 2006. Fcg receptors: old friends and new family members. Immunity 24: 19-28.
37. Deisenhofer, J. 1981. Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution. Biochemistry 20: 2361-2370. (Pubitemid 11089772)
38. Derrick, J. P., and D. B. Wigley. 1992. Crystal structure of a streptococcal protein G domain bound to an Fab fragment. Nature 359: 752-754.
39. Sauer-Eriksson, A. E., G. J. Kleywegt, M. Uhlén, and T. A. Jones. 1995. Crystal structure of the C2 fragment of streptococcal protein G in complex with the Fc domain of human IgG. Structure 3: 265-278.
40. Bruggemann, M., G. T. Williams, C. I. Bindon, M. R. Clark, M. R. Walker, R. Jefferis, H. Waldmann, and M. S. Neuberger. 1987. Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J. Exp. Med. 166: 1351-1361.
41. Bindon, C. I., G. Hale, M. Brüggemann, and H. Waldmann. 1988. Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q. J. Exp. Med. 168: 127-143.
42. Ades, E. W., D. J. Phillips, S. L. Shore, D. S. Gordon, M. G. LaVia, C. M. Black, and C. B. Reimer. 1976. Analysis of mononuclear cell surfaces with fluoresceinated staphylococcal protein A complexed with IgG antibody of heat-aggregated γ-globulin. J. Immunol. 117: 2119-2123.
43. Flesch, B. K., and J. Neppert. 2000. Functions of the Fc receptors for immunoglobulin G. J. Clin. Lab. Anal. 14: 141-156.
44. Wines, B. D., M. S. Powell, P. W. Parren, N. Barnes, and P. M. Hogarth. 2000. The IgG Fc contains distinct Fc receptor (FcR) binding sites: the leukocyte receptors Fc γ RI and Fc γ RIIa bind to a region in the Fc distinct from that recognized by neonatal FcR and protein A. J. Immunol. 164: 5313-5318.
45. Zhang, L., K. Jacobsson, J. Vasi, M. Lindberg, and L. Frykberg. 1998. A second IgG-binding protein in Staphylococcus aureus. Microbiology 144: 985-991. (Pubitemid 28187924)
46. Atkins, K. L., J. D. Burman, E. S. Chamberlain, J. E. Cooper, B. Poutrel, S. Bagby, A. T. Jenkins, E. J. Feil, and J. M. H. van den Elsen. 2008. S. aureus IgG-binding proteins SpA and Sbi: host specificity and mechanisms of immune complex formation. Mol. Immunol. 45: 1600-1611.
47. Lewis, M. J., M. Meehan, P. Owen, and J. M. Woof. 2008. A common theme in interaction of bacterial immunoglobulin-binding proteins with immunoglobulins illustrated in the equine system. J. Biol. Chem. 283: 17615-17623.
48. Fraser, J., V. Arcus, P. Kong, E. Baker, and T. Proft. 2000. Superantigens - powerful modifiers of the immune system. Mol. Med. Today 6: 125-132.
49. Rooijakkers, S. H., M. Ruyken, A. Roos, M. R. Daha, J. S. Presanis, R. B. Sim, W. J. van Wamel, K. P. van Kessel, and J. A. van Strijp. 2005. Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat. Immunol. 6: 920-927.
50. de Haas, C. J., K. E. Veldkamp, A. Peschel, F. Weerkamp, W. J. Van Wamel, E. C. J. M. Heezius, M. J. J. G. Poppelier, K. P. Van Kessel, and J. A. van Strijp. 2004. Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J. Exp. Med. 199: 687-695.
51. Lijnen, H. R., F. D. Cock, O. Matsuo, and D. Collen. 1992. Comparative fibrinolytic and fibrinogenolytic properties of staphylokinase and streptokinase in plasma of different species in vitro. Fibrinolysis 6: 33-37.
52. Prévost, G., B. Cribier, P. Couppié, P. Petiau, G. Supersac, V. Finck-Barbançon, H. Monteil, and Y. Piemont. 1995. Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities. Infect. Immun. 63: 4121-4129.